Back to Authors

Ng, Eric W

Mayo Clinic

A2 Biotherapeutics, Inc., Agoura Hills, CA, USA

Citations 1

588 EVEREST-1: initial safety data from a seamless phase 1/2 study of A2B530, a logic-gated Tmod CAR T-cell therapy, in patients with solid tumors associated with CEA expression also exhibiting HLA-LOH
Grierson, Patrick , Welling, Theodore H., Lim, Kian-Huat, Morelli, Maria Pia , Patel, Sandip Pravin , Ulrickson, Matthew L. , Kundranda, Madappa N. , Vong, Judy, Mitchell, Jasmine , Langeberg, Wendy J., Bretzlaff, William, Nikiforow, Sarah , Mardiros, Armen, Maloney, David G. , Liechty, Kirstin B., Hecht, J. Randolph , Go, William Y., Molina, Julian R. , Punekar, Salman R. , Hazim, Antonious , Simeone, Diane M. , Kirtane, Kedar , Lim, Kian-Huat , Castria, Tiago Biachi De , Maus, Marcela V , Locke, Frederick L. , Ng, Eric W

Regular and Young Investigator Award Abstracts | November 5, 2024 | Volume: No volume available | Issue: No issue available | Pages: A670-A671

10.1136/jitc-2024-sitc2024.0588 Get It